Howard G. Welgus insider trades: Arcutis Biotherapeutics (ARQT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Howard reports to the SEC
Open-market buys and sales
57 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | ARQT | ↓ Sell | 4,728 | $26.93 | $127K | Direct | Oct 19, 2026 (4d) |
| Sep 15, 2026 | ARQT | ↓ Sell | 4,730 | $24.18 | $114K | Direct | Sep 17, 2026 (2d) |
| Aug 17, 2026 | ARQT | ↓ Sell | 4,730 | $26.18 | $124K | Direct | Aug 19, 2026 (2d) |
| Jul 15, 2026 | ARQT | ↓ Sell | 4,730 | $26.91 | $127K | Direct | Jul 17, 2026 (2d) |
| Jun 17, 2026 | ARQT | ↓ Sell | 4,731 | $24.58 | $116K | Direct | Jun 17, 2026 (0d) |
| May 1, 2026 | ARQT | ↓ Sell | 7,144 | $22.99 | $164K | Direct | May 5, 2026 (4d) |
| Apr 1, 2026 | ARQT | ↓ Sell | 10,000 | $23.88 | $239K | Direct | Apr 3, 2026 (2d) |
| Mar 2, 2026 | ARQT | ↓ Sell | 10,000 | $25.65 | $257K | Direct | Mar 4, 2026 (2d) |
| Feb 2, 2026 | ARQT | ↓ Sell | 10,000 | $25.05 | $250K | Direct | Feb 4, 2026 (2d) |
| Jan 2, 2026 | ARQT | ↓ Sell | 10,000 | $28.96 | $290K | Direct | Jan 6, 2026 (4d) |
| Dec 1, 2025 | ARQT | ↓ Sell | 10,000 | $30.21 | $302K | Direct | Dec 3, 2025 (2d) |
| Nov 3, 2025 | ARQT | ↓ Sell | 10,000 | $25.27 | $253K | Direct | Nov 5, 2025 (2d) |
| Oct 1, 2025 | ARQT | ↓ Sell | 10,000 | $18.92 | $189K | Direct | Oct 3, 2025 (2d) |
| Sep 2, 2025 | ARQT | ↓ Sell | 10,000 | $15.64 | $156K | Direct | Sep 4, 2025 (2d) |
| Aug 1, 2025 | ARQT | ↓ Sell | 10,000 | $14.30 | $143K | Direct | Aug 5, 2025 (4d) |
| Jul 1, 2025 | ARQT | ↓ Sell10b5-1 | 9,208 | $13.84 | $127K | Direct | Jul 2, 2025 (1d) |
| Jun 18, 2025 | ARQT | ↓ Sell10b5-1 | 10,139 | $13.37 | $136K | Direct | Jun 20, 2025 (2d) |
| May 1, 2025 | ARQT | ↓ Sell10b5-1 | 10,000 | $14.64 | $146K | Direct | May 5, 2025 (4d) |
| Apr 1, 2025 | ARQT | ↓ Sell10b5-1 | 10,000 | $15.12 | $151K | Direct | Apr 3, 2025 (2d) |
| Mar 3, 2025 | ARQT | ↓ Sell10b5-1 | 10,000 | $13.00 | $130K | Direct | Mar 4, 2025 (1d) |
| Feb 3, 2025 | ARQT | ↓ Sell10b5-1 | 10,000 | $12.71 | $127K | Direct | Feb 4, 2025 (1d) |
| Jan 2, 2025 | ARQT | ↓ Sell10b5-1 | 10,000 | $14.67 | $147K | Direct | Jan 6, 2025 (4d) |
| Dec 2, 2024 | ARQT | ↓ Sell10b5-1 | 10,000 | $12.51 | $125K | Direct | Dec 3, 2024 (1d) |
| Nov 1, 2024 | ARQT | ↓ Sell10b5-1 | 10,000 | $8.65 | $87K | Direct | Nov 5, 2024 (4d) |
| Oct 1, 2024 | ARQT | ↓ Sell | 10,000 | $9.26 | $93K | Direct | Oct 3, 2024 (2d) |
| Sep 3, 2024 | ARQT | ↓ Sell | 10,000 | $10.77 | $108K | Direct | Sep 5, 2024 (2d) |
| Aug 1, 2024 | ARQT | ↓ Sell | 10,000 | $9.87 | $99K | Direct | Aug 5, 2024 (4d) |
| Jul 1, 2024 | ARQT | ↓ Sell | 10,000 | $9.31 | $93K | Direct | Jul 2, 2024 (1d) |
| Jun 4, 2024 | ARQT | ↓ Sell | 10,000 | $8.01 | $80K | Direct | Jun 6, 2024 (2d) |
| Apr 17, 2023 | ARQT | ↓ Sell | 8,500 | $13.97 | $119K | Direct | Apr 18, 2023 (1d) |
| Apr 6, 2023 | ARQT | ↓ Sell | 8,500 | $12.01 | $102K | Direct | Apr 10, 2023 (4d) |
| Feb 15, 2023 | ARQT | ↓ Sell | 8,500 | $16.98 | $144K | Direct | Feb 21, 2023 (6d) |
| Jan 17, 2023 | ARQT | ↓ Sell | 8,500 | $13.72 | $117K | Direct | Jan 18, 2023 (1d) |
| Nov 15, 2022 | ARQT | ↓ Sell | 3,403 | $20.01 | $68K | Direct | Nov 17, 2022 (2d) |
| Oct 4, 2022 | ARQT | ↓ Sell | 6,000 | $20.29 | $122K | Direct | Oct 6, 2022 (2d) |
| Aug 15, 2022 | ARQT | ↓ Sell | 6,000 | $24.80 | $149K | Direct | Aug 17, 2022 (2d) |
| Jul 18, 2022 | ARQT | ↓ Sell | 6,000 | $24.40 | $146K | Direct | Jul 18, 2022 (0d) |
| Jun 1, 2022 | ARQT | ↓ Sell | 2,500 | $20.62 | $52K | Direct | Jun 2, 2022 (1d) |
| May 2, 2022 | ARQT | ↓ Sell | 2,500 | $20.44 | $51K | Direct | May 3, 2022 (1d) |
| Apr 1, 2022 | ARQT | ↓ Sell | 7,500 | $20.02 | $150K | Direct | Apr 1, 2022 (0d) |
| Jan 3, 2022 | ARQT | ↓ Sell | 2,500 | $21.21 | $53K | Direct | Jan 5, 2022 (2d) |
| Dec 23, 2021 | ARQT | ↓ Sell | 2,500 | $20.16 | $50K | Direct | Dec 23, 2021 (0d) |
| Nov 1, 2021 | ARQT | ↓ Sell | 2,500 | $21.81 | $55K | Direct | Nov 3, 2021 (2d) |
| Oct 1, 2021 | ARQT | ↓ Sell | 2,500 | $23.87 | $60K | Direct | Oct 5, 2021 (4d) |
| Sep 1, 2021 | ARQT | ↓ Sell | 5,000 | $20.80 | $104K | Direct | Sep 3, 2021 (2d) |
| Jul 1, 2021 | ARQT | ↓ Sell | 2,200 | $26.13 | $57K | Direct | Jul 6, 2021 (5d) |
| Jun 1, 2021 | ARQT | ↓ Sell | 2,200 | $27.09 | $60K | Direct | Jun 3, 2021 (2d) |
| May 3, 2021 | ARQT | ↓ Sell | 2,200 | $34.79 | $77K | Direct | May 5, 2021 (2d) |
| Apr 1, 2021 | ARQT | ↓ Sell | 2,200 | $29.49 | $65K | Direct | Apr 5, 2021 (4d) |
| Mar 1, 2021 | ARQT | ↓ Sell | 2,200 | $34.37 | $76K | Direct | Mar 3, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ARQT insiders
Open-market trades in the last 12 months
About Howard G. Welgus's insider trades
Howard G. Welgus is a director at Arcutis Biotherapeutics (ARQT). Since Aug 3, 2020, Howard has reported no open-market purchases and 57 sales worth $6.8M on SEC Form 4. In the last 12 months: 11 sales ($2.1M).
9 sales (17% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (50 filings), grants and awards (7 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARQT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.